Examples of 'temsirolimus' in a sentence
Meaning of "temsirolimus"
Temsirolimus is a drug that is used to treat certain types of cancer, particularly kidney cancer
Show more definitions
- An intravenous drug for the treatment of renal cell carcinoma, a derivative of sirolimus.
How to use "temsirolimus" in a sentence
Basic
Advanced
temsirolimus
Temsirolimus has been associated with phospholipidosis in rats.
Torisel contains the active substance temsirolimus.
It is unknown whether temsirolimus is excreted in human breast milk.
Temsirolimus is a selective inhibitor of mTOR mammalian target of rapamycin.
There is no specific treatment for temsirolimus overdose.
Temsirolimus is cleared predominantly by the liver.
Concomitant use of temsirolimus with sunitinib.
Temsirolimus has not been studied in patients undergoing haemodialysis.
It contains the active substance temsirolimus.
A temsirolimus composition may also be administered parenterally or intraperitoneally.
The active substance is temsirolimus.
The excretion of temsirolimus in milk has not been studied in animals.
Vaccinations may be less effective while being treated with temsirolimus.
Temsirolimus and sirolimus pharmacokinetics are not significantly affected by gender.
Age does not appear to affect temsirolimus and sirolimus pharmacokinetics significantly.
See also
Temsirolimus may increase your cholesterol and fats in the blood.
There are no adequate data from the use of temsirolimus in pregnant women.
No dose adjustment of temsirolimus is recommended in patients with renal impairment.
Transplanted kidneys since sirolimus is released from temsirolimus in the body.
A combination of temsirolimus and herceptin in the treatment of cancer is provided.
This compound is now known generically under the name temsirolimus.
The known association of temsirolimus with hyperlipaemia may predispose to myocardial infarction.
In another embodiment rapamycin derivatives are selected from temsirolimus and everolimus.
Patients on temsirolimus with baseline neutropaenia may be at risk of developing febrile neutropaenia.
The use of live vaccines should be avoided during treatment with temsirolimus.
Dose of temsirolimus.
Temsirolimus should be used with caution when treating patients with hepatic impairment.
Monitoring of complete blood count is recommended prior to initiating temsirolimus therapy and periodically thereafter.
The use of temsirolimus was associated with increases in serum triglycerides and cholesterol.
Serum cholesterol and triglycerides should be tested before and during treatment with temsirolimus.
Patients on temsirolimus with baseline neutropenia may be at risk of developing febrile neutropenia.
Monitoring of complete blood count is recommended prior to initiating temsirolimus therapy and peridically thereafter.
The dose of temsirolimus that can be safely given with etoposide and cyclophosphamide.
Summary of efficacy results in temsirolimus MCL clinical trial.
Temsirolimus dose modifications based on weekly ANC and platelet counts.
Renal impairment No dose adjustment of temsirolimus is recommended in patients with renal impairment.
Use of temsirolimus in patients with MCL with moderate or severe hepatic impairment.
Assessment of AST and bilirubin levels is recommended before initiation of temsirolimus and periodically after.
Hepatic impairment Temsirolimus is cleared predominantly by the liver.
For the HPLC determination of the chromatographic purity of Temsirolimus and.
Amphiphilic agents Temsirolimus has been associated with phospholipidosis in rats.
Co-administration of lenalidomide does not alter the pharmacokinetics of temsirolimus.
Hepatic impairment Temsirolimus should be used with caution in patients with hepatic impairment.
In certain embodiments, mTOR inhibitors include everolimus and temsirolimus.
Paediatric population Temsirolimus and sirolimus pharmacokinetics in the paediatric population have not been investigated.
Therefore, inhibitors of these metabolic pathways are not expected to affect the elimination of temsirolimus.
New trial results on pazopanib and temsirolimus have important implications for patients with RCC.
Temsirolimus is used to treat cancer of the kidneys, also called renal cell carcinoma.
Mean half-lives of temsirolimus and sirolimus were.
Figure 17 depicts the effect of solids concentration on particle size of temsirolimus containing particles.
